documents: FDA-2005-D-0460-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2005-D-0460-0005 FDA FDA-2005-D-0460 Pediatric Drug Development: Regulatory Considerations—Complying With the Pediatric Research Equity Act and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act; Draft Guidance for Industry; Availability Notice Notice of Availability 2023-05-18T04:00:00Z 2023 5 2023-05-18T04:00:00Z   2023-05-19T11:42:41Z 2023-10610 0 0 0900006485a1c56a

Links from other tables